LION POINT CAPITAL, LP
Adviser information for LION POINT CAPITAL, LP last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Partnership |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 9 |
|---|---|
| Investment Advisory/Research | 4 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 6 | $517.7M |
| Non-Discretionary | 0 | $0 |
| Total | 6 | $517.7M |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 6 | $517.7M |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 50 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based feesPERFORMANCE-BASED ALLOCATIONS |
| Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
250 W 55TH STREET33RD FLOOR
NEW YORK
NY
United States
Monday - Friday, 8:00 AM - 5:00 PM
Tel: 212-356-6200, Fax: 212-356-6201
Websites
Chief Compliance Officer
IRSHAD KARIM
GENERAL COUNSEL
250 W 55TH STREET
33RD FLOOR
NEW YORK
NY
United States
Tel:
212-356-6200
I*****@************M
(Full email address available in API data)
Industry Affiliates
| LION POINT CAPITAL GP III, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| LION POINT CAPITAL GP, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| LION POINT LIFE SCIENCES PARTNERS, LP | Hedge Fund | $26.9M | $1.0M | 5 |
| LION POINT MASTER, LP | Hedge Fund | $350.3M | $0.1M | 63 |
| SUNSHINE SPV LLC | Private Equity Fund | $133.3M | $0.0M | 27 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| CEDERHOLM, CARL, DIDRIC MARCUS | Individual | – | CHIEF INVESTMENT OFFICER | 08/2014 | < 5% |
| MURPHY, JAMES, DANIEL | Individual | – | CHIEF OPERATING OFFICER | 08/2014 | < 5% |
| LION POINT HOLDINGS GP LLC | Domestic Entity | – | GENERAL PARTNER | 08/2014 | < 5% |
| CEDERHOLM, CARL, DIDRIC MARCUS | Individual | LION POINT HOLDINGS GP LLC | MANAGER | 04/2015 | |
| KARIM, IRSHAD, S | Individual | – | GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER | 09/2015 | < 5% |
| LEJONUDDEN FAMILY LLC | Domestic Entity | LION POINT HOLDINGS GP LLC | MEMBER | 04/2015 | > 75% |
| CEDERHOLM, CARL, DIDRIC MARCUS | Individual | LEJONUDDEN FAMILY LLC | MEMBER AND MANAGER | 03/2015 | > 75% |
| LEJONUDDEN FAMILY LLC | Domestic Entity | – | LIMITED PARTNER | 04/2015 | > 75% |
| FRANOV, ANA | Individual | – | CHIEF FINANCIAL OFFICER | 01/2019 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| ALPHABET INC | CAP STK CL C | 18K | 100 | – |
| ARDELYX INC | COM | 6M | 857K | – |
| AVADEL PHARMACEUTICALS PLC | COM SHS | 1M | 83K | – |
| BATTALION OIL CORP | COM | 25K | 7K | – |
| BLUEBIRD BIO INC | COM | 668K | 678K | – |
| BRIDGEBIO PHARMA INC | COM | 1M | 49K | – |
| BURGERFI INTERNATIONAL INC | COM | 557K | 3M | – |
| BURGERFI INTERNATIONAL INC | *W EXP 12/16/202 | 26K | 2M | – |
| ENPHYS ACQUISITION CORP | CL A ORD SHS | 858K | 78K | – |
| FENNEC PHARMACEUTICALS INC | COM | 1M | 170K | – |
| GERON CORP | COM | 3M | 630K | – |
| INSMED INC | COM PAR $.01 | 5M | 70K | – |
| ISHARES TR | RUSSELL 2000 ETF | 17M | 83K | – |
| JASPER THERAPEUTICS INC | COM NEW | 726K | 32K | – |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | 2M | 105K | – |
| LUMOS PHARMA INC | COM | 211K | 91K | – |
| MARINUS PHARMACEUTICALS INC | COM NEW | 2M | 2M | – |
| MICROSOFT CORP | COM | 45K | 100 | – |
| MILESTONE PHARMACEUTICALS IN | COM | 3M | 2M | – |
| MINERALYS THERAPEUTICS INC | COM | 924K | 79K | – |
| MIRUM PHARMACEUTICALS INC | COM | 2M | 45K | – |
| NEUROCRINE BIOSCIENCES INC | COM | 1M | 8K | – |
| REGENXBIO INC | COM | 424K | 36K | – |
| SERES THERAPEUTICS INC | COM | 247K | 341K | – |
| SPDR SER TR | S&P BIOTECH | 5M | 50K | – |
| SPRUCE BIOSCIENCES INC | COM | 39K | 75K | – |
| SYNDAX PHARMACEUTICALS INC | COM | 1M | 65K | – |